Evidence map›Paper›PMID 29392891›Full record

ArticleAngewandte Chemie (International ed. in English)2018

Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front-Line Tuberculosis Drugs.

Frances P Rodriguez-Rivera, Xiaoxue Zhou, Julie A Theriot, Carolyn R Bertozzi

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Aerosolization of viableProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. A Fluorogenic Trehalose Probe for Tracking PhagocytosedJournal of the American Chemical Society · 2020
    Article
  16. Review
  17. Article
  18. Review
  19. Microbiology spectrum · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Frances P Rodriguez-RiveraDepartment of Chemistry, University of California, Berkeley, CA, 94720, USA.
Xiaoxue ZhouDepartment of Biochemistry, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Julie A TheriotDepartment of Biochemistry, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Carolyn R BertozziDepartment of Chemistry, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0003-4482-2754
Howard Hughes Medical Institute · USStanford University · USUniversity of California, Berkeley · US

Funding

TRAINING & OUTREACH COREP50GM107615 · NIGMS · STANFORD UNIVERSITY · PI COVERT, MARKUS W · 2013 to 2017
$10.9M
Mycobacterial Sulfation PathwaysR01AI051622 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2002 to 2015
$6.0M
METABOLIC OLIGOSACCHARIDE ENGINEERINGR01GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Carolyn Bertozzi · 1999 to 2026
$5.6M
Chemical MycobateriologyR37AI051622 · NIAID · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2016 to 2025
$4.7M
Metabolic Engineering with Bioorthogonal Chemical ReportersR37GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2009 to 2018
$4.7M
Actin-Based Motility of a Bacterial PathogenR37AI036929 · NIAID · UNIVERSITY OF WASHINGTON · PI THERIOT, JULIE A. · 2010 to 2019
$3.0M
ACTIN BASED MOTILITY OF A BACTERIAL PATHOGENR01AI036929 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI THERIOT, JULIE A. · 1995 to 2009
$2.2M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI036929NIAID NIH HHS R01 AI051622NIAID NIH HHS R37 AI036929NIAID NIH HHS R37 AI051622NIGMS NIH HHS P50 GM107615NIGMS NIH HHS R01 GM058867NIGMS NIH HHS R37 GM058867
6 · The paper itself

Abstract

Front-line tuberculosis (TB) drugs have been characterized extensively in vitro and in vivo with respect to gene expression and cell viability. However, little work has been devoted to understanding their effects on the physiology of the cell envelope, one of the main targets of this clinical regimen. Herein, we use metabolic labeling methods to visualize the effects of TB drugs on cell envelope dynamics in mycobacterial species. We developed a new fluorophore-trehalose conjugate to visualize trehalose monomycolates of the mycomembrane using super-resolution microscopy. We also probed the relationship between mycomembrane and peptidoglycan dynamics using a dual metabolic labeling strategy. Finally, we found that metabolic labeling of both cell envelope structures reports on drug effects on cell physiology in two hours, far faster than a genetic sensor of cell envelope stress. Our work provides insight into acute drug effects on cell envelope biogenesis in live mycobacteria.

Indexed as

Antitubercular AgentsCell MembraneMicrobial Sensitivity TestsMycobacterium tuberculosisTuberculosisAntitubercular Agentscell envelopedrug discoverylive-cell imagingmetabolic labelingmycobacteria

Identifiers

PMID29392891
PMCPMC5924460
OpenAlexW2791246471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.